Nasopharyngeal carcinoma epidemiology and demographics

	Nasopharyngeal carcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Nasopharyngeal carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Nasopharyngeal carcinoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Nasopharyngeal carcinoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Nasopharyngeal carcinoma epidemiology and demographics
CDC on Nasopharyngeal carcinoma epidemiology and demographics
Nasopharyngeal carcinoma epidemiology and demographics in the news
Blogs on Nasopharyngeal carcinoma epidemiology and demographics
Directions to Hospitals Treating Nasopharyngeal carcinoma
Risk calculators and risk factors for Nasopharyngeal carcinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

The incidence of nasopharyngeal carcinoma is different based on the geographic areas. The incidence in the USA is approximately 0.2 to 0.5 per 100,000 individuals, in Alaska and Greenland is 15 to 20 per 100,000 individuals and the highest incidence is seen in southeast Asia, North Africa, southern China and middle east with the incidence of 80 per 100,000 individuals.^[1]^[2]

In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
The case-fatality rate/mortality rate of [disease name] is approximately [number range].

The incidence of nasopharyngeal carcinoma increases with increasing age in low- risk population. However, in high risk populations, the maximum incidence is seen in indivituals around ages 50 to 59 and then the incidence decreases by increasing age .

There is no racial predilection to [disease name].
[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Nasopharyngeal carcinoma are more commonly affected by male than female. The male to female ratio is approximately 2-3 to 1.

[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Nasopharyngeal carcinomas account for approximately 70% of all primary malignancies of the nasopharynx.
Although it is rare in Western populations, it is one of the most common malignancies in Asia. Nasopharyngeal carcinoma is thought to be very common in Southern China, accounting for approximately 18% of all cancers in China.

↑ Caponigro, Francesco; Longo, Francesco; Ionna, Franco; Perri, Francesco (2010). "Treatment approaches to nasopharyngeal carcinoma: a review". Anti-Cancer Drugs. 21 (5): 471–477. doi:10.1097/CAD.0b013e328337160e. ISSN 0959-4973.
↑ Lee, Anne W.M.; Ng, W.T.; Chan, Y.H.; Sze, Henry; Chan, Connie; Lam, T.H. (2012). "The battle against nasopharyngeal cancer". Radiotherapy and Oncology. 104 (3): 272–278. doi:10.1016/j.radonc.2012.08.001. ISSN 0167-8140.